According to a new report Global Coronary stents Market, published by KBV research, The Global Coronary stents Market size is expected to reach $13.2 billion by 2024, rising at a market growth of 8.5% CAGR during the forecast period.
The Polymer Based Coatings market dominated the Global Coronary Stents Market by Drug-eluting stents (DES) Type in 2017. The Polymer Free Coatings market is expected to witness a CAGR of 8.5% during (2018 - 2024).
The North America market would dominate the Global Bioresorbable Vascular Scaffold Market by 2024, growing at a CAGR of 9.2 % during the forecast period. The Europe market is expected to witness a CAGR of 9.4% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 13.1% during (2018 - 2024).
The Drug-eluting stents (DES) market dominated the Global Coronary Stents Market by Product Type in 2017. The Bare-Metal Stents market is expected to witness a CAGR of 8.2% during (2018 - 2024). Additionally, The Bioresorbable Vascular Scaffold market is expected to witness highest CAGR of 10.6% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/global-coronary-stents-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT, Terumo Medical Corporation, Medtronic Plc., B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc., Cook Medical Incorporated, Johnson & Johnson, Biotronik SE & Co. KG, Biosensors International Group Ltd.
By Product Type
By Geography
Companies Profiled
Unique Offerings from KBV Research
Related Reports:
North America Coronary Stent Market